Join
This site is intended for healthcare professionals
1
Role of Post-Exposure Prophylaxis in COVID-19
2
Screens Driving Horrific Harm to Children’s Health
3
Gut Microbiome Predicts Response to Diabetes Drugs
4
EMJ Innovations 10.1 2026
5
Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment
Checkpoint-Engineered Particles Induce Food Allergy Tolerance
Simple Fitness Test Predicts Pulmonary Hypertension Outcomes
Photoprotection May Preserve Epigenetic Stability in Human Skin
GLP-1 RAs Reduce Adverse Limb Events in Patients with Diabetes
Scalable chikungunya vaccine breakthrough
EMJ’s Latest Flagship Journal
AI Models Combine Genomics and Demographics to Predict Gastric Cancer Risk
Mullein Leaf Extract Shows Antibacterial Promise
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
Targeted Treatment Improved Survival in Cholangiocarcinoma
Rollout of AI Scribe Tools Transform NHS Consultations
Nomogram Predicts Atrial Fibrillation Recurrence After Cryoballoon Ablation
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
Psychosocial Stress Raises Risk of Dementia and Stroke
AI System Improves MRI Breast Cancer Diagnosis
Computer-Aided Detection Chest X-Ray Matches Radiologists
Sleep Quality Linked to Favourable ART Outcomes
Key Predictors of Death in Septic Shock Identified
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk